$SBFM

$2.65 -$0.35 (11.67%) Close

$SBFM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$SBFM Management Team

Mr. Michel Roy

Chief Commercial Officer

Age 57

Compensation -

Sex Male

Dr. Steve Slilaty

Chairman of the Board

President

Chief Executive Officer

Age 72

Compensation $1.292M USD

Sex Male

Mr. Camille Sebaaly

Chief Financial Officer

Secretary

Age 63

Compensation $352.0K USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Michel Roy Chief Commercial Officer	57	-	Male
Dr. Steve Slilaty Chairman of the Board President Chief Executive Officer	72	$1.292M USD	Male
Mr. Camille Sebaaly Chief Financial Officer Secretary	63	$352.0K USD	Male

Board of Directors

From the proxy statement filed Oct 23, 2025

Directors

serving now

Independent

3 of 3

stated in the proxy; 2 not stated

Average tenure

6.5 years

from year joined

CEO also chairs the board

Yes

Steve N. Slilaty

Director	Age	On board	Independent	Committees	Other public boards	Pay
Steve N. Slilaty Board chair, CEO	73	2009 16 years	Not stated	None stated	None stated	Paid as CEO
Rabi Kiderchah	52	2021 4 years	Independent	None stated	None stated	Not stated
David Natan	72	2022 3 years	Independent	None stated	FiEE Inc.	Not stated
Andrew Keller	72	2022 3 years	Independent	None stated	None stated	Not stated
Abderrazzak Merzouki Leaving at the meeting	Not stated	Not stated	Not stated	None stated	None stated	Not stated

Nominated to join at the meeting

Not on the board yet; they join only if elected.

Camille Sebaaly · 64

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Oct 23, 2025

Dr. Slilaty

Purchase price equal to the stated value of $0.10 per share

2024

Sale of 20,000 shares of Series B Preferred Stock at a purchase price equal to the stated value of $0.10 per share.

With we Open in proxy

Dr. Slilaty

Purchase price equal to the stated value of $0.10 per share

2024

Sale of 100,000 shares of Series B Preferred Stock at a purchase price equal to the stated value of $0.10 per share.

With we Open in proxy

Comments

Company Executives

$SBFM Management Team

Mr. Michel Roy

Dr. Steve Slilaty

Mr. Camille Sebaaly

Board of Directors

Related-party transactions